European committee takes a second look at Alzheimer's drug and now says it should be approved
A European regulatory committee now recommends approval of the Alzheimer’s treatment lecanemab a few months after rejecting ...
What Will Elon Musk Actually Do for “Government Efficiency”? Unfortunately, We Already Know.
It may be tough to single out any particular ones as the worst of the bunch, but allow me to suggest two contenders: tech ...